3516d купить от 377,00 руб.

3516D is a novel biosensor platform for detection of biomarkers in blood. The platform uses 3D-printed microfluidics and state-of-the-art optics to detect and quantify biomarkers such as glucose, lactate, cholesterol, and cytokines. The device is designed to be used in point-of-care settings, such as hospitals, clinics, and home care.

The 3516D platform is based on the 3D printed microfluidics technology, which allows for precise control over the fluidic environment and sample preparation. It also features a novel imaging system that can be used to quantify the biomarkers of interest. This is achieved by using a CMOS sensor, such as the OV4689, which has a high dynamic range and low noise.

One of the advantages of the 3516D biosensor platform is its ability to analyze multiple biomarkers simultaneously. This allows for a more comprehensive understanding of the health status of a patient. Additionally, the platform can be easily integrated into existing healthcare infrastructure, making it a viable option for point-of-care testing.

In conclusion, the 3516D Biosensor Platform is a promising technology for the detection and quantification of biomarkers in blood samples. Its unique combination of 3D printing, microfluidics, and state-of-the-art optics makes it a powerful tool for clinicians and researchers alike.